{"id":"arformoterol-25-g-bid","safety":{"commonSideEffects":[{"rate":"5-10","effect":"Tremor"},{"rate":"5-8","effect":"Headache"},{"rate":"2-5","effect":"Palpitations"},{"rate":"2-4","effect":"Muscle cramps"},{"rate":"2-4","effect":"Nervousness"},{"rate":"1-3","effect":"Tachycardia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As the active R-enantiomer of formoterol, arformoterol selectively activates beta-2 adrenergic receptors on bronchial smooth muscle, leading to increased intracellular cAMP and smooth muscle relaxation. This produces sustained bronchodilation lasting approximately 12 hours, making it suitable for twice-daily dosing in chronic obstructive pulmonary disease and asthma management.","oneSentence":"Arformoterol is a long-acting beta-2 adrenergic agonist that binds to beta-2 receptors on airway smooth muscle to cause bronchodilation and improve airflow.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:42:59.654Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic obstructive pulmonary disease (COPD) maintenance therapy"},{"name":"Asthma maintenance therapy"}]},"trialDetails":[{"nctId":"NCT00250679","phase":"PHASE3","title":"Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"Sumitomo Pharma America, Inc.","startDate":"2005-10","conditions":"Chronic Obstructive Pulmonary Disease, Bronchitis, Emphysema","enrollment":443}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Brovana","R,R formoterol"],"phase":"phase_3","status":"active","brandName":"Arformoterol 25 ųg BID","genericName":"Arformoterol 25 ųg BID","companyName":"Sumitomo Pharma America, Inc.","companyId":"sumitomo-pharma-america-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Arformoterol is a long-acting beta-2 adrenergic agonist that binds to beta-2 receptors on airway smooth muscle to cause bronchodilation and improve airflow. Used for Chronic obstructive pulmonary disease (COPD) maintenance therapy, Asthma maintenance therapy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}